Abraxis to open biopharmaceutical campus in Culver City.Abraxis BioScience bioscience /bio·sci·ence/ (-si´ens) the study of biology wherein all the applicable sciences (physics, chemistry, etc.) are applied. bi·o·sci·ence n. See life science. Inc. has bought a 3.5-acre property in Culver City Culver City, city (1990 pop. 38,793), Los Angeles co., S Calif., a residential suburb of Los Angeles; inc. 1917. It is a center of the U.S. motion-picture industry, whose roots in the city date to c.1915. Its chief manufactures are rubber products and computers. for a new research and development facility. The biopharmaceutical campus, with a planned 2008 completion date, is intended to bring together the company's proprietary research, development and clinical trial operations. Abraxis, created by the merger of Santa Monica-based American BioScience Inc. and Schaumburg, Ill.-based American Pharmaceutical Partners Inc., has been operating out of American BioScience's offices. In addition to the Culver City property, Abraxis said it has acquired a 50,750-square-foot laboratory facility in Marina Marina “a piece of virtue.” [Br. Lit.: Pericles] See : Virtuousness del Rey Del Rey may refer to:
In addition to the Los Angeles-area facilities, Abraxis retains American Pharmaceutical's manufacturing facility in Illinois, which makes Abraxane and several injectible genetic drags. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion